Alaunos Therapeutics, Inc. (TCRT)
Recent Filing Index
| Form | Filed | Qtr End | F_Period | 8K: Earnings Release |
|---|---|---|---|---|
| 10-QLatest | Q1-2026 | — | ||
| 10-K/A | FY-2025 | |||
| 10-KLatest | FY-2025 | — | ||
| 10-Q | Q3-2025 | — | ||
| 10-Q | Q2-2025 | — | ||
| 10-Q | Q1-2025 | — | ||
| 10-K/A | FY-2024 | |||
| 10-K | FY-2024 | — | ||
| 10-Q | Q3-2024 | 8-K (2024-10-10) | ||
| 10-Q | Q2-2024 | — | ||
| 10-Q | Q1-2024 | — | ||
| 10-K | FY-2023 | — | ||
| 10-Q | Q3-2023 | 8-K (2023-11-14) · 99.1 | ||
| 10-Q | Q2-2023 | 8-K (2023-08-14) · 99.1 |
Filing Summary
| Report Name | Notes | Fiscal Period (Annual) | Fiscal Period (Quarter) |
|---|---|---|
| Cover Page | ||
| Statements | ||
| Balance Sheets | ||
| Balance Sheets (P) | ||
| Statements of Operations | ||
| Statements of Changes In Stockholders' Equity | ||
| Statements of Cash Flows | ||
| Notes | ||
| Accrued Expenses | — |
|
| Commitments and Contingencies | ||
| Cybersecurity Risk Management, Strategy and Governance | — |
|
| Debt | ||
| Employee Benefit Plan | — |
|
| Equity | ||
| Fair Value Measurements | — |
|
| Financings | ||
| Income Taxes | — |
|
| Insider Trading Arrangements | ||
| Insider Trading Policies and Procedures | — |
|
| Joint Venture | ||
| Leases | ||
| Net Earnings Per Share | — |
|
| Net Loss Per Share | — |
|
| Organization | ||
| Pay Vs Performance Disclosure | ||
| Property and Equipment, Net | — |
|
| Related Party Transactions | ||
| Restructuring | ||
| Segment Information | ||
| Stock Option Plan | — |
|
| Stock-based Compensation | — |
|
| Subsequent Events | ||
| Summary of Significant Accounting Policies | ||
| Warrants | ||